WALTHAM, Massachusetts, March 28 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its April 2024 edition (Vol. 3, No. 4):

Original Articles:

* Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials

* CAR T-Cell Immunotherapy in Minority Patients with Lymphoma